Edition:
India

Resverlogix Corp (RVX.TO)

RVX.TO on Toronto Stock Exchange

2.96CAD
22 Jul 2019
Change (% chg)

-- (--)
Prev Close
$2.96
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
114,338
52-wk High
$4.94
52-wk Low
$2.30

About

Resverlogix Corp is Canada-based clinical-stage biotechnology company. The Company is developing apabetalone (RVX-208), a molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is the BET inhibitor... (more)

Overall

Beta: 0.88
Market Cap(Mil.): $606.90
Shares Outstanding(Mil.): 204.13
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates